Schiano Moriello Aniello, Bossoni Aurora, Mattoteia Daiana, Caprioglio Diego, Minassi Alberto, Appendino Giovanni, De Petrocellis Luciano, Amodeo Pietro, Vitale Rosa Maria
Institute of Biomolecular Chemistry, National Research Council (ICB-CNR), Via Campi Flegrei 34, 80078 Pozzuoli, NA, Italy.
Epitech Group SpA, Via Leonardo Da Vinci 3, 35030 Saccolongo, PD, Italy.
Int J Mol Sci. 2025 Mar 17;26(6):2682. doi: 10.3390/ijms26062682.
Phytocannabinoids (pCBs) from represent an important class of bioactive molecules, potentially useful for the treatment of a wide range of diseases. Their efficacy is due to their ability to interact with multiple targets of the endocannabinoid system, including the thermosensitive transient receptor potential (Thermo-TRPs), namely TRPV1-4, TRPA1, and TRPM8 channels. Previously, we demonstrated a shift in selectivity toward TRPA1 in the activity profile of the main pCBs, that is, CBD, ∆-THC, CBG, CBC, and CBN, by swapping the pentyl chain with the α,α-dimethylheptyl (DMH) one. Using these derivatives as a starting point, here we investigate the effects on the thermo-TRPs activity profile of the integration of a quinone group into the resorcinol scaffold. We found that, while the activity on TRPA1 is substantially retained, an increase in potency/efficacy on the TRPV3 modulation is observed. Docking studies were used to elucidate the binding modes of the most active compounds toward this receptor, providing a rationale for this biological activity. In summary, we show that the quinone derivatives of DMH-pCBs are endowed with a TRPA1/TRPV3 desensitizing activity, potentially useful for the treatment of skin diseases sustained by inflammatory conditions.
来自[具体来源未提及]的植物大麻素(pCBs)是一类重要的生物活性分子,可能对多种疾病的治疗有用。它们的功效归因于其与内源性大麻素系统的多个靶点相互作用的能力,包括热敏性瞬时受体电位(Thermo-TRPs),即TRPV1-4、TRPA1和TRPM8通道。此前,我们通过将戊基链与α,α-二甲基庚基(DMH)链交换,证明了主要pCBs(即CBD、∆-THC、CBG、CBC和CBN)的活性谱中对TRPA1的选择性发生了变化。以这些衍生物为起点,我们在此研究将醌基团整合到间苯二酚支架中对Thermo-TRPs活性谱的影响。我们发现,虽然对TRPA1的活性基本得以保留,但观察到对TRPV3调节的效力/功效有所增加。对接研究用于阐明最具活性的化合物与该受体的结合模式,为这种生物活性提供了理论依据。总之,我们表明DMH-pCBs的醌衍生物具有TRPA1/TRPV3脱敏活性,可能对治疗由炎症条件引起的皮肤病有用。